Literature DB >> 7425570

Distal neuropathy in experimental diabetes mellitus.

M J Brown, A J Sumner, D A Greene, S M Diamond, A K Asbury.   

Abstract

Although nerve conduction slowing is a well-accepted abnormality in rats with acute experimental diabetes, reports of neuropathological changes in diabetic rat nerves have been inconsistent. To examine this further, we studied electrophysiological and morphological features of posterior tibial nerves and their distal branches from four-week streptozotocin-induced diabetic rats and matched controls. Diabetic rat posterior tibial motor conduction was slowed (mean +/- 1 SD, 34.8 +/- 3.1 m/sec; controls, 41.2 +/- 2.5 m/sec), and evoked muscle response amplitudes were only half of control values. Using quantitative techniques, we documented a diminution in number of the largest myelinated fibers in otherwise normal mid posterior tibial nerves, with an increase in the smaller sizes, indicating either a degree of axonal atrophy or impaired fiber growth during development. The principal pathological finding was active breakdown of myelinated fibers in the most distal motor twigs of hindfoot muscles supplied by posterior tibial branches, with preservation of fibers in more proximal segments of these nerves. This anatomical lesion in diabetic nerves could account for both oberved conduction slowing and lowered muscle response amplitudes. A consistent feature in both diabetic and control mid lateral plantar nerves was a zone of demyelination that apparently occurs at this natural site of nerve entrapment in rats. Taken together, the pathological abnormalities of peripheral nerve in acute experimental diabetes are best explained as resulting from a distal axonopathy.

Entities:  

Mesh:

Year:  1980        PMID: 7425570     DOI: 10.1002/ana.410080207

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  20 in total

1.  Symptomatic focal mononeuropathies in diabetic patients: increased or not?

Authors:  Elefterios Stamboulis; Demetris Vassilopoulos; Nikolaos Kalfakis
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

2.  Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic mice.

Authors:  J A Christianson; J M Ryals; M S Johnson; R T Dobrowsky; D E Wright
Journal:  Neuroscience       Date:  2006-12-16       Impact factor: 3.590

3.  Effects of nerve compression on fast axonal transport in streptozotocin-induced diabetes mellitus. An experimental study in the sciatic nerve of rats.

Authors:  L B Dahlin; K F Meiri; W G McLean; B Rydevik; J Sjöstrand
Journal:  Diabetologia       Date:  1986-03       Impact factor: 10.122

4.  Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat.

Authors:  L B Dahlin; D R Archer; W G McLean
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

5.  An efficient sampling scheme for estimating fibre number from nerve cross sections: the fractionator.

Authors:  T M Mayhew
Journal:  J Anat       Date:  1988-04       Impact factor: 2.610

6.  Sciatic nerve morphology and morphometry in mature rats with streptozocin-induced diabetes.

Authors:  A Wright; H Nukada
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  Diabetic neuropathy. Human and experimental.

Authors:  P K Thomas
Journal:  Drugs       Date:  1986       Impact factor: 9.546

8.  Distal axonopathy in streptozotocin diabetes in rats.

Authors:  S Chokroverty; D Seiden; P Navidad; R Cody
Journal:  Experientia       Date:  1988-05-15

9.  Transport of myo-inositol into endoneurial preparations of sciatic nerve from normal and streptozotocin-diabetic rats.

Authors:  K R Gillon; J N Hawthorne
Journal:  Biochem J       Date:  1983-03-15       Impact factor: 3.857

10.  Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.

Authors:  K R Gillon; J N Hawthorne; D R Tomlinson
Journal:  Diabetologia       Date:  1983-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.